FDA Investigator Gregory W Smith

Gregory W Smith has inspections in 1 countries as of 30 Aug 2023. Gregory W Smith has collaborated with a combinined 4022 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
253
Last Inspection Date:
30 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
A Williams, Aaron L Dunbar, Aimee J Edwin, Alan M Roberts, Alan R Albrecht, Alfred P Pistorio, Alicia M Mozzachio, Amos, Amy L Mcintyre, Ana M Placencia, Anders W Evenson, Andrea B Slavin, Anthony J Ladner, April L Brown, April L Young, Baask, Benedict, Benjamin W Anderson, Bili Jom Johnson, Billi Jom Johnson, Brian E Thompson, Brian L Szcyubialka, Bruce Huang, Bunce, Carolyn A Warren, Charles R Bonapace, PhD, Charles R Core, Charles R Cote, RIC, Chase Bourke, PhD, Chhagan Tele, Christina A Castineyra, Christina L Bigham, Christine M Erickson, Como, Connie L Richard, Constance L Richard, Constance Lrichard Math, Corey K Reno, Corey Reno, Courtney R Ingalsbe, Courtney R Tiegs, Dacia E Quick, Dale A Nyberg, Darlene L Krieger, Darren D Holaday, David B Wieneke, David J Ward, Demetria L Lueneburg, Denise L Burosh, Denise M Digiulio, Diane T Reindl, Dianna C Sonnenburg, Dina A Tallman, Donald R Goldsmith, Douglas J Snyder, Douglas W Atkins, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhou Chen (nmi), MD PhD, Duc Minh H Nguyen, Edward A Fabiano, Edward M James, Elizabeth P Mayer, Ellen C Weisensel, Emily E Harlow, Emily E Markgraf, English, Eric A Breselow, Fallon J Ryan, Fannie M Harrell, Frank S Sedzielarz, Gerald E Scholze, Gina M Scholze, Grant M Ruis, Greg W Smith, Gregory S Larson, Gregory Smith, Harperd, Heather Akleimola Hulbert, Howard A Burmester, Hustedtj, Hyojong Kwon, PhD, Ivan E Reyes, Jaclyn N Munsch, Jacob W Reynolds, Jake T Lane, James A Beaulieu, James K Ireland, Jan L Hewett, Janis R Armedoriz, Jasjeet K Sekhon, Jean M Trimbo, Jeanne M Morris, Jeffery A Hangartner, Jeffry A Bernhardt, Jennifer Al Vollon, Jennifer Alongie Vollom, Jennifer R Mathern, Jennifer S Ness, Jeremy L Tri, Jesse P Romenesko, Jessica L Barr, Jessica L Johnson, Jessica M Novak, Jocelyn M Muggli, Joel D Hustedt, John E Emmert, John T Quaife, Jon C Polzine, Jonathan G Gayechuway, Jonathan G Swoboda, Jonathan L Blonk, Jonell R O'neil, Joseph D Gong, Joseph J Golden, Joseph M Edwin, Justin A Boyd, Jyoti B Patel, PhD, Kara A Scheibner, PhD, Karen M Labounty, Karla J Youngberg, Katherine A Clarke Girolamo, Kathryn M Mogen, Kellie L Thommes, RN, Kellie L Westerbuhr, Kenneth A Libertoski, Kevin P Regan, Kibily D Dembele, Krista K Petersen, Kristy E Zuroski, Kristy Zivski, Kyle J Mccracken, Larae M Koopman, Lauren E Merz, Lauren E Sanger, Leonardm, Linda V Weyer, Lisa M Lopez, Lori B Wikstrom, Lori S Lawless, M Edith Snyder, Mada A Tautges, Maere A Fadden, Margaret L Bolte, Margaret M Lubbers Solberg, Maria E Treadwell, Marie A Fadden, Maril A Fadden, Marissa S Henning, Marissa S Steinhagen, Martin K Yau, PhD, Melissa D Kalik, Melissa I Michurski, Melissa I Stittsworth, Michele L Glendenning, Michele Perry Williams, Mohammed H Adam, Msdap Gonzlezk, Nicole C Shokatz, Nicole C Victoria, PhD, Paola E Lathrop, Patricia A Holmstrom, Patrick J Campbell, Patrick J Lynch, Peter T Erlandson, Ralph Jerndal, Rebecca L Caulfield, Rebecca L Keller, Rebecca L Mullikin, Rebecca L Zamora, Richard Jay Tucker, RS, Richard M Willey, Robert F Leuer, MDA, Robert H Claflin, Robert J Waldorf, Ronald R Ruff, Rosario D'costa, Ross J Grigsby, Rostislav Servetnyk, Ryan P Morgan, Sana A Elassar, Sandra A Boyd, Sandra A Hughes, Sandra Sejdinovic, Sarah A Palmer, Scott A Golladay, Scott B Laufenberg, Scott B Lausanberg, Scott B Loufoubery, Scott T Ballard, Scott T Panagiotis, Seth A Abbott, Shalonda C Clifford, Shannon M Berg, Sharon K Thoma, PharmD, Sharon L Matson, Sharon M Harold, Shaun M Olson, Soyinka S Eneng, State Agency, Steven A Skaar, Steven J Crowston, Susan M Matthias, Susan M Miller, Suzanne M Crotty, Tara C Singh, Tara M Carolfi, Theresa C Klaman, Thomas S Donaldson, Tony T Yang, Traci C Kelm, Tracy A Solseng, Troy A Brenny, Tyler R Courtney, Tyson J Eldridge Stedman, Victoria L Palmer, Wayne W Grundstrom, Wendy L Trefethren Grang, William E Keer, William Hallett, PhD, Xiaohan Cai, PhD, Yehualashet A Gessesse, Yiyue Zhang (nmi), PhD, Zachary P Wachlarowicz

Gregory W Smith's Documents

Publish Date Document Type Title
November, 2000 FDA 483 Eniva USA, Inc. - Form 483, 2000-11-17
November, 2000 EIR Natural Biologics Llc - EIR, 2000-11-30
March, 2006 FDA 483 Hobart Laboratories, Inc - Form 483, 2006-03-09
October, 2007 FDA 483 ANI Pharmaceuticals, Inc. - Form 483, 2007-10-05
October, 2003 EIR DIVERSIFIED MANUFACTURING CORP - EIR, 2003-10-02
February, 2007 FDA 483 Innovative Chemical Corporation - Form 483, 2007-02-21
December, 2000 EIR Hawkins, Inc. - EIR, 2000-12-12
October, 2003 FDA 483 DIVERSIFIED MANUFACTURING CORP - Form 483, 2003-10-02
February, 2001 EIR Pace Analytical Life Sciences, LLC - EIR, 2001-02-13
August, 2003 EIR Cima Labs, Inc. - EIR, 2003-08-01
September, 2001 EIR Patterson Dental Supply, Inc. - EIR, 2001-09-24
November, 2000 FDA 483 Natural Biologics Llc - Form 483, 2000-11-30
August, 2001 FDA 483 Reed Drug - Form 483, 2001-08-17
August, 2001 FDA 483 Lobana Industries LLC - Form 483, 2001-08-30
November, 2000 EIR ANI Pharmaceuticals, Inc. - EIR, 2000-11-01
August, 2003 FDA 483 Cima Labs, Inc. - Form 483, 2003-08-01
April, 2001 FDA 483 Apothecary Products, LLC - Form 483, 2001-04-05
August, 2002 FDA 483 ANI Pharmaceuticals, Inc. - Form 483, 2002-08-16
August, 2003 FDA 483 Cima Labs, Inc. - Form 483, 2003-08-01
October, 2001 FDA 483 Scribe Manufacturing Inc - Form 483, 2001-10-01
October, 2001 FDA 483 Orphan Medical, Inc. - Form 483, 2001-01-10
October, 2001 EIR Orphan Medical, Inc. - EIR, 2001-01-09
May, 2002 EIR Padagis US LLC - EIR, 2002-05-31
January, 2007 FDA 483 Scribe Manufacturing Inc - Form 483, 2007-01-26
October, 2001 EIR Orphan Medical, Inc. - EIR, 2001-10-01
September, 2010 FDA 483 NAMSA - Form 483, 2010-09-03
October, 2001 FDA 483 Response Orphan Medical, Inc. - Form 483R, 2001-02-06
August, 2003 EIR Cima Labs, Inc. - EIR, 2003-08-01
May, 2002 FDA 483 Padagis US LLC - Form 483, 2002-05-31

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more